DE69428403D1 - Verfahren zur Herstellung von Azetidinverbindungen und Ausgangsverbindungen dafür - Google Patents

Verfahren zur Herstellung von Azetidinverbindungen und Ausgangsverbindungen dafür

Info

Publication number
DE69428403D1
DE69428403D1 DE69428403T DE69428403T DE69428403D1 DE 69428403 D1 DE69428403 D1 DE 69428403D1 DE 69428403 T DE69428403 T DE 69428403T DE 69428403 T DE69428403 T DE 69428403T DE 69428403 D1 DE69428403 D1 DE 69428403D1
Authority
DE
Germany
Prior art keywords
compounds
preparation
therefor
azetidine
starting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69428403T
Other languages
English (en)
Other versions
DE69428403T2 (de
Inventor
Tameo Iwasaki
Kazuhiko Kondo
Hiroshi Ohmizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of DE69428403D1 publication Critical patent/DE69428403D1/de
Application granted granted Critical
Publication of DE69428403T2 publication Critical patent/DE69428403T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/04Preparation by forming the ring or condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69428403T 1993-06-23 1994-06-23 Verfahren zur Herstellung von Azetidinverbindungen und Ausgangsverbindungen dafür Expired - Lifetime DE69428403T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15189993 1993-06-23

Publications (2)

Publication Number Publication Date
DE69428403D1 true DE69428403D1 (de) 2001-10-31
DE69428403T2 DE69428403T2 (de) 2002-06-20

Family

ID=15528629

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69428403T Expired - Lifetime DE69428403T2 (de) 1993-06-23 1994-06-23 Verfahren zur Herstellung von Azetidinverbindungen und Ausgangsverbindungen dafür

Country Status (3)

Country Link
US (2) US5550229A (de)
EP (1) EP0635488B1 (de)
DE (1) DE69428403T2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731431A (en) * 1991-12-26 1998-03-24 Nippon Soda Co., Ltd. Process for preparing 4-substituted azetidinone derivatives
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
JPH09143156A (ja) * 1995-11-17 1997-06-03 Tanabe Seiyaku Co Ltd アセトキシアゼチジノン誘導体の製法及びその合成中間体
JP3450193B2 (ja) * 1998-07-24 2003-09-22 高砂香料工業株式会社 4−置換アゼチジノン誘導体の製造方法
AU4343500A (en) * 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
US7667076B2 (en) * 2005-09-14 2010-02-23 Regents Of The University Of California Amide forming chemical ligation
US8841444B2 (en) * 2008-07-30 2014-09-23 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
CA2774715C (en) 2009-07-27 2018-04-03 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
NZ604478A (en) 2010-07-02 2014-12-24 Gilead Sciences Inc Fused heterocyclic compounds as ion channel modulators
EA028156B9 (ru) 2011-05-10 2018-01-31 Джилид Сайэнс, Инк. Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
TWI478908B (zh) 2011-07-01 2015-04-01 Gilead Sciences Inc 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (de) 2011-07-01 2018-04-28
CN102367239B (zh) * 2011-07-20 2015-10-28 沈阳药科大学 2-芳基-2,3-二氢-4h-1,3-苯并噻嗪-4-酮衍生物及其用途
CN102977134A (zh) * 2012-12-13 2013-03-20 凯莱英医药集团(天津)股份有限公司 碳青霉烯中间体β-甲基-ADC-8的制备方法
WO2017132321A1 (en) 2016-01-29 2017-08-03 The Johns Hopkins University Novel inhibitors of bacterial growth
CN111440102B (zh) * 2020-04-26 2022-02-15 大连凯飞化学股份有限公司 一种二硫代二苯甲酰胺类化合物的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU433549B2 (en) * 1968-10-10 1973-03-09 Chhom Gyogyszer Es Vegyeszeti Termeker Ciara N New 4 quinazoline derivatives and process forthe preparation thereof
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
EP0010348A1 (de) * 1978-09-12 1980-04-30 Imperial Chemical Industries Plc Heterocyclische Trichlormethyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US4640915A (en) * 1982-03-29 1987-02-03 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives
JPS6019764A (ja) * 1983-07-13 1985-01-31 Sankyo Co Ltd アゼチジノン誘導体の製造法
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
JPS615081A (ja) * 1984-06-18 1986-01-10 Sankyo Co Ltd 1−置換カルバペネム−3−カルボン酸誘導体の製造法
DK270685A (da) * 1984-06-29 1985-12-30 Hoffmann La Roche Carbapenemderivater
ES8800215A1 (es) * 1985-03-29 1987-10-16 Merck & Co Inc Un procedimiento enantioselectivo para la preparacion de intermedios para los antibioticos de 1-b-metil-carbapenem
JPS61275267A (ja) * 1985-03-29 1986-12-05 メルク エンド カムパニ− インコ−ポレ−テツド 1−β−メチルカルバペネム抗生物質中間体の鏡像異性選択的製造方法
EP0213610A1 (de) * 1985-08-31 1987-03-11 Lederle (Japan) Ltd. Azetidin-2-on-Derivate und Verfahren zu ihrer Herstellung
JPS62158277A (ja) * 1986-01-07 1987-07-14 Sumitomo Pharmaceut Co Ltd β−ラクタム誘導体
JPS62252785A (ja) * 1986-01-08 1987-11-04 Sankyo Co Ltd 4−置換β−ラクタム化合物
JPS62169781A (ja) * 1986-01-21 1987-07-25 Sankyo Co Ltd β−ラクタム化合物
JP2789190B2 (ja) * 1986-01-27 1998-08-20 住友製薬株式会社 新規なβ−ラクタム誘導体およびその製造法
GB8607921D0 (en) * 1986-04-01 1986-05-08 Fujisawa Pharmaceutical Co 3,4-disubstituted-2-azetidinone derivatives
JPH0759581B2 (ja) * 1986-09-05 1995-06-28 日本レダリ−株式会社 (1r)−1−メチルカルバペネム−3−カルボン酸誘導体
JPS6363680A (ja) * 1986-09-05 1988-03-22 Nippon Redarii Kk (1r)−1−メチルカルバペネム−3−カルボン酸誘導体
DE3632916A1 (de) * 1986-09-27 1988-03-31 Bayer Ag Enantiomerenreine 2-azetidinone, verfahren zu ihrer herstellung und ihre verwendung
JPH0713058B2 (ja) * 1986-12-29 1995-02-15 日本レダリ−株式会社 4―置換アゼチジノン誘導体の製造方法
JPS6425778A (en) * 1987-04-11 1989-01-27 Lederle Japan Ltd (1r,5s,6s)-2-((1,2,3-thiadiazolium-4-yl)methyl)thio-6-((r)-1-hydroxyethyl)-1-methyl-carbapenem-3-carboxylate
JPS63255280A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk (1r,5s,6s)−2−置換−6−〔(r)−1−ヒドロキシエチル〕−1−メチル−カルバペネム−3−カルボン酸誘導体
JPS63255281A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk (1r,5s,6s)−2−〔(ピラジニウム−2−イル)メチル〕チオ−6−〔(r)−1−ヒドロキシエチル〕−1−メチル−カルバペネム−3−カルボキシレ−ト
JPS63255282A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk (1r,5s,6s)−2−〔(チアゾリウム−2−イル)または(イミダゾリウム−2−イル)メチル〕チオ−6−〔(r)−1−ヒドロキシエチル〕−1−メチル−カルバペネム−3−カルボキシレ−ト
JPS63255284A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk (1r,5s,6s)−2−〔(置換ピリジニウム−2−イル)メチル〕チオ−6−〔(r)−1−ヒドロキシエチル〕−1−メチル−カルバペネム−3−カルボキシレ−ト
JPS6425779A (en) * 1987-04-11 1989-01-27 Lederle Japan Ltd (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative
JPS63255283A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk (1r,5s,6s)−2−〔(3−置換イミダゾリニウム−1−イル)アルキル〕チオ−6−〔(r)−1−ヒドロキシエチル〕−1−メチル−カルバペネム−3−カルボキシレ−ト
JPS63284176A (ja) * 1987-05-15 1988-11-21 Nippon Redarii Kk (1r,5r,6s)−6−〔(1r)−1−ヒドロキシエチル〕−1−メチルカルバペネム−3−カルボン酸誘導体の高立体選択的製造方法
JPH02788A (ja) * 1988-01-07 1990-01-05 Fujisawa Pharmaceut Co Ltd 3,4―ジ置換―2―アゼチジノン誘導体
IE66711B1 (en) * 1988-04-01 1996-01-24 Sankyo Co 2-(heterocyclylthio) carbapenem derivatives their preparation and their use as antibiotics
JPH02292269A (ja) * 1989-05-06 1990-12-03 Lederle Japan Ltd 活性アミド化合物
CA2050255C (en) * 1990-09-07 1997-02-04 Tameo Iwasaki 1-methylcarbapenem derivatives and process for preparation thereof
JP3220985B2 (ja) * 1991-12-26 2001-10-22 日本曹達株式会社 4−置換アゼチジノン誘導体の製造方法
JPH0665195A (ja) * 1992-08-24 1994-03-08 Banyu Pharmaceut Co Ltd β−ラクタム誘導体の新規な製造法
US5442055A (en) * 1992-11-13 1995-08-15 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof

Also Published As

Publication number Publication date
US5550229A (en) 1996-08-27
EP0635488A2 (de) 1995-01-25
EP0635488A3 (de) 1995-08-23
US5703234A (en) 1997-12-30
DE69428403T2 (de) 2002-06-20
EP0635488B1 (de) 2001-09-26

Similar Documents

Publication Publication Date Title
DE69416236D1 (de) Verfahren zur Herstellung von Isocyanatoorganosilanen
DE69428403D1 (de) Verfahren zur Herstellung von Azetidinverbindungen und Ausgangsverbindungen dafür
DE69426173T2 (de) Verfahren zur Herstellung von beta-Cyanoalkylsilanen
DE69424446D1 (de) Verfahren zur Herstellung von Alkylsulfinylbenzamiden
DE69432649D1 (de) Verfahren zur Herstellung von 1-Halogen-1-jodethan
DE69403042T2 (de) Verfahren zur Herstellung von Alkylcyclopentadienen
DE59407416D1 (de) Verfahren zur Herstellung von N-Alkenylpyrrolidonen
DE69417526D1 (de) Verfahren zur Herstellung von cis-1-Aminoindan-2-ol
DE69306099T2 (de) Verfahren zur Herstellung von Monoalkenylbenzolen
DE59401893D1 (de) Verfahren zur Herstellung von Trifluormethylanilinen
DE59401525D1 (de) Verfahren zur Herstellung von Acetoacetarylamiden
DE59402596D1 (de) Verfahren zur Herstellung von 5-Acetoacetylaminobenzimidazolon-2
DE69408813T2 (de) Verfahren zur Herstellung von Diol-Verbindungen
DE59403834D1 (de) Verfahren zur Herstellung von m-Chloraromaten
DE59405751D1 (de) Verfahren zur Herstellung von Aminopropionitrilen
DE69409551T2 (de) Verfahren zur Herstellung von 2-Chloro-5-aminomethylpyridinen
DE69404103D1 (de) Verfahren zur Herstellung von Dibenzylaminen
DE69407865D1 (de) Verfahren zur Herstellung von Nitrophenolen
DE59400502D1 (de) Verfahren zur Herstellung von Acylcyclopropanen
DE59407426D1 (de) Verfahren zur Herstellung von Fluorbenzonitrilen
DE69400951T2 (de) Verfahren zur Herstellung von Dicyclopentyldichlorosilan
DE59407425D1 (de) Verfahren zur Herstellung von Fluornitrobenzolen
DE59400136D1 (de) Verfahren zur Herstellung von Anthrachinonamin-Verbindungen
DE69304508T2 (de) Verfahren zur Herstellung von Monoalkenylbenzolen
DE69411648T2 (de) Verfahren zur Herstellung von Monoalkenylbenzolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition